Controlled Substances: DEA Should Take Additional Actions to Reduce Risks in Monitoring the Continued Eligibility of Its Registrants

Home > Diane Publishing Books >

Product price is not filled in. This product cannot be purchased.

By Seto J. Bagdoyan (au)
Year: 2016
Pages: 66
Binding Paperback
ISBN 978-1-4578-6426-1

Product Code: 1457864266

Description

The Drug Enforcement Administration (DEA) registers individuals and entities authorized to manufacture, distribute, or dispense controlled substances in accordance with the Controlled Substances Act, which seeks to ensure that only authorized individuals handle controlled substances. States also have a role in the registration process as they determine general licensing requirements for health-care professionals who are permitted to handle or prescribe controlled substances. Controlled substances include prescription pain relievers, such as OxyContin, stimulants, and sedatives. This report assesses the extent to which DEAäó»s internal controls help ensure that individual registrants are and remain eligible and do not present issues that may increase the risk of illicit diversion, among other objectives. Tables and figures. This is a print on demand report.

Share your knowledge of this product with other customers... Be the first to write a review